Modeling cardiac arrest and resuscitation in the domestic pig

• 作者: Albert H Olivencia-Yurvati Anh Q Nguyen Brandon H Cherry Robert T Mallet Roger A Hollrah
• 来源期刊: 世界重症医学杂志
• 学科: 医学
• 关键词: ACIDEMIA ASPHYXIA CARDIOPULMONARY RESUSCITATION Countershocks HYPEROXIA VASOPRESSIN Ventricular fibrillation
• 年，卷（期）: sjzzyxzz_2015,（1）
• 页码范围: 1-12
• 页数: 12页
• 分类号: R

摘要

Cardiac arrest remains a leading cause of death and permanent disability worldwide.Although many victims are initially resuscitated,they often succumb to the extensive ischemia-reperfusion injury inflicted on the internal organs,especially the brain.Cardiac arrest initiates a complex cellular injury cascade encompassing reactive oxygen and nitrogen species,Ca2+overload,ATP depletion,pro-and anti-apoptotic proteins,mitochondrial dysfunction,and neuronal glutamate excitotoxity,which injures and kills cells,compromises function of internal organs and ignites a destructive systemic inflammatory response.The sheer complexity and scope of this cascade challenges the development of experimental models of and effective treatments for cardiac arrest.Many experimental animal preparations have been developed to decipher the mechanisms of damage to vital internal organs following cardiac arrest and cardiopulmonary resuscitation(CPR),and to develop treatments to interrupt the lethal injury cascades.Porcine models of cardiac arrest and resuscitation offer several important advantages over other species,and outcomes in this large animal are readily translated to the clinical setting.This review summarizes porcine cardiac arrest-CPR models reported in the literature,describes clinically relevant phenomena observed during cardiac arrest and resuscitation in pigs,and discusses numerous methodological considerations in modeling cardiac arrest/CPR.Collectively,published reports show the domestic pig to be a suitable large animal model of cardiac arrest which is responsive to CPR,defibrillatory countershocks and medications,and yields extensive information to foster advances in clinical treatment of cardiac arrest.